Weight Loss
Tirzepatide
Dual-action weight loss. Real, lasting results.
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works on two separate hunger-regulating pathways at once. That dual action makes it one of the most effective tools available for meaningful, sustained weight loss.
Starting at $249.99/month
10% off your first month. Reflects the 1-month intro price.
Free expedited Rx shipping to all 50 states.
Free telehealth consultation. Pay only if a provider approves your treatment plan.
A licensed provider determines the right dose for you.
HSA and FSA accepted.
Compounded in a licensed pharmacy.
Medically reviewed by:Medura Clinical Team
Last updated:July 21, 2026
Why patients choose Medura.
Real providers, not AI
Every treatment plan is reviewed by a licensed provider who has time to know your full medical history, not just your symptoms.
Transparent pricing, no surprises
See the exact price before you start. No hidden fees, no surprise charges at checkout, no auto-escalating "optimization" costs.
Made in FDA-registered U.S. facilities
Compounded and quality-tested domestically. Discreet packaging. We cover shipping on all plans.
Support that actually listens
Your care team stays with you long after the first shipment. Real check-ins, dose adjustments based on how you actually feel, and honest answers to real questions.
What this is
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works on two separate hunger-regulating pathways at once. That dual action makes it one of the most effective tools available for meaningful, sustained weight loss.
A licensed provider builds your plan, starts you at a low dose, and guides you upward at a pace your body can handle. You get real clinical support, not a generic protocol.
What to expect
Your treatment timeline, so you know what's coming and when to expect real changes.
- 1
Two hormones, one injection
Tirzepatide activates both GIP and GLP-1 receptors, targeting appetite from two distinct biological pathways, something no single-agonist treatment can match.
- 2
Gradual dose titration
You start low and increase on a schedule your provider controls. This keeps side effects manageable while your body adapts.
- 3
Results that compound
Most patients notice reduced hunger and improved satiety in the first weeks. Significant body weight changes build over months with consistent dosing.
How Tirzepatide works differently
Unlike older GLP-1 medications, Tirzepatide activates two separate gut hormone receptors. This dual mechanism has produced some of the highest average weight loss results ever recorded in a clinical obesity trial.
Dual-receptor action
By targeting both GIP and GLP-1 receptors, Tirzepatide signals fullness more completely than a single-agonist approach, reducing both hunger and caloric intake.
Clinically significant weight loss
In clinical trials, patients on the highest dose lost an average of 22% of their body weight over 72 weeks, among the strongest outcomes ever documented.
Provider-guided from day one
A licensed provider reviews your history, sets your starting dose, and stays available to adjust your plan based on how you respond.
Lab tested medications for quality and potency.
Every medication ships from a licensed U.S. pharmacy in our network, delivered straight to your door.
Third party quality control testing
Compounded in U.S. pharmacies
Safety and eligibility
This treatment is prescription-only. Your eligibility will be determined during your free consultation with a provider based on your full medical history, current medications, and health goals. Nothing on this page guarantees approval.
Generally appropriate for:
- •Adults with a BMI over 27 seeking medically-supervised weight loss
- •People who have not achieved adequate results with diet and exercise alone
- •Those looking for sustainable, long-term weight management support
- •Adults without a history of thyroid or pancreatic conditions
Generally not appropriate if:
- •Pregnant or breastfeeding individuals
- •People with a personal or family history of medullary thyroid carcinoma
- •Those with multiple endocrine neoplasia syndrome type 2 (MEN 2)
- •Patients with a history of pancreatitis without prior provider evaluation
Common side effects:
Nausea (most common, especially early in treatment, typically improves)
Decreased appetite (expected and therapeutic)
Mild diarrhea or constipation
Occasional vomiting or stomach discomfort
These typically subside as your body adjusts to the medication
Individual results vary. This is not a complete list of potential side effects. Your provider will review all risks during your consultation.
"I tried semaglutide before but stalled out. Tirzepatide completely changed things. The hunger just stopped being a constant battle."
Monica R.
Down 34 lbs in 5 months
Results vary. Individual outcomes depend on the user's starting point, adherence to the treatment plan, lifestyle factors, and overall health.
Questions, answered
You might also explore
Learn more about Tirzepatide
Expert guidance from the Medura care team
Semaglutide for Weight Loss: How It Works, Who It's For, and What to Expect
Learn how semaglutide supports weight loss, what the FDA approval covers, who may be a candidate, and how to get started through Medura's licensed provider network.
Fasting for Beginners: A Step-by-Step Guide
Start fasting gently and build gradually. A realistic week-by-week progression and common mistakes to avoid.
Unlock your free metabolic health guide
Get your complete six-week plan to reset your metabolism, rebuild energy, and restore your body's natural fat-burning power. No crash diets, no extremes. Just a practical blueprint backed by science.